Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 4Phase 1/2 2Phase 2/3 1

Status

Completed 4

Sponsor Class

NIH 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 23Gynecologic 4Dermatologic 4Endocrine 3Thoracic 2Other hematologic neoplasm 2Genitourinary 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Myeloid 1Head & Neck 1CNS 1Breast 1

Conditions

Ovarian Neoplasms 2Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 233Carboplatin 217Bevacizumab 139Cisplatin 136pembrolizumab 89Gemcitabine 69olaparib 54Docetaxel 47Topotecan 44Radiotherapy 43liposomal doxorubicin 41Taxes 41niraparib 38Cyclophosphamide 36Doxorubicin 30Drug Therapy 29Letrozole 28Nivolumab 27Magnetic Resonance Spectroscopy 25Immunoglobulin G 25Disulfides 24Oxaliplatin 23Albumin-Bound Paclitaxel 23durvalumab 22apatinib 21Etoposide 21Brachytherapy 21lenvatinib 20camrelizumab 20Specimen Handling 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × aflibercept × Gynecologic × Clear all
NCT00462826 2019-07-23

VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer

National Cancer Institute (NCI)

Phase 2 Completed
49 enrolled 13 charts
Gynecologic

Endometrial Neoplasms

NCT00327171 2016-06-07

Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer

Sanofi

Phase 2 Completed
218 enrolled 19 charts
Gynecologic

Neoplasms, Ovarian Neoplasms

NCT00390234 2015-12-07

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed
63 enrolled 10 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00396591 2013-01-10

AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites

Sanofi

Phase 2 Completed
16 enrolled 18 charts
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡